wire - news in brief
« BACK
Pharmacology - Chemistry - 22.08.2023
Pharmacology - Health - 14.07.2023
Health - Pharmacology - 27.04.2023
Pharmacology - Life Sciences - 25.04.2022
Pharmacology - Health - 17.03.2022
Health - Pharmacology - 09.02.2022
Health - Pharmacology - 03.02.2022
Health - Pharmacology - 03.02.2022
Health - Pharmacology - 01.02.2022
Health - Pharmacology - 31.01.2022
Pharmacology - Campus - 22.09.2021
Health - Pharmacology - 26.07.2021
Health - Pharmacology - 23.06.2021
Health - Pharmacology - 26.01.2021
Pharmacology - 10.05.2020
Pharmacology - 23.12.2019
Pharmacology - Health - 16.12.2019
Pharmacology - Health - 01.12.2019
Social Sciences - Pharmacology - 18.11.2019
Pharmacology - 04.09.2019
Health - Pharmacology - 01.04.2019
Health - Pharmacology - 06.12.2018
Pharmacology
Results 1 - 22 of 22.
VUB chemist mimics natural protein to accelerate drug development
Professor Steven Ballet, head of the Organic Chemistry research group at the Vrije Universiteit Brussel, has received the international Evotec Award for Excellence in Molecular Design from the French Société de Chimie Thérapeutique.
Professor Steven Ballet, head of the Organic Chemistry research group at the Vrije Universiteit Brussel, has received the international Evotec Award for Excellence in Molecular Design from the French Société de Chimie Thérapeutique.
Clinnova to Launch Precision Medicine Initiative Across Europe
Inaugurating a new initiative to foster AI-driven precision medicine via data federation, standardisation, and interoperability.
Inaugurating a new initiative to foster AI-driven precision medicine via data federation, standardisation, and interoperability.
VUB Hematology and UZ Brussel win prizes
The Hematology-Immunology research group at VUB and the Hematology department UZ Brussel have received three awards for their research into better treatment of blood cancer.
The Hematology-Immunology research group at VUB and the Hematology department UZ Brussel have received three awards for their research into better treatment of blood cancer.
Better communication should lead to more appropriate care for young cancer patients
"The goal is to improve communication between young cancer patients (between 10 and 18 years old), their parents and the medical staff, and thereby also optimise care," says Anne van Driessche, third
"The goal is to improve communication between young cancer patients (between 10 and 18 years old), their parents and the medical staff, and thereby also optimise care," says Anne van Driessche, third
Researchers study partial failure of immunotherapy
The teams of VUB professors Bart Neyns, Sandra Tuyaerts and Karine Breckpot will join research groups from UCL, Bordet Institute and ULB in their search for factors that explain why current immunotherapies fail in all patients.
The teams of VUB professors Bart Neyns, Sandra Tuyaerts and Karine Breckpot will join research groups from UCL, Bordet Institute and ULB in their search for factors that explain why current immunotherapies fail in all patients.
Helping cancer patients fulfil their desire to have children
Professors Michel De Vos and Ellen Anckaert work at UZ Brussel and are affiliated with VUB.
Professors Michel De Vos and Ellen Anckaert work at UZ Brussel and are affiliated with VUB.
Majority favour Covid vaccination
Flemish are more positive about vaccine than Walloons; half of non-vaccinated people do not want to be vaccinated The Vrije Universiteit Brussel and VUB spin-off iCense conducted a survey among Belgians to find out people's reasons for choosing to be vaccinated against Covid-19 or not.
Flemish are more positive about vaccine than Walloons; half of non-vaccinated people do not want to be vaccinated The Vrije Universiteit Brussel and VUB spin-off iCense conducted a survey among Belgians to find out people's reasons for choosing to be vaccinated against Covid-19 or not.
ETheRNA and VUB expand strategic collaboration to engineer next generation mRNA therapeutics with TetraMix
Extension to proven TriMix adjuvant technology intended to boost dendritic cell activation eTheRNA immunotherapies NV ('eTheRNA', Niel, Belgium ), a clinical-stage company developing mRNA-based immun
Extension to proven TriMix adjuvant technology intended to boost dendritic cell activation eTheRNA immunotherapies NV ('eTheRNA', Niel, Belgium ), a clinical-stage company developing mRNA-based immun
Belgian initiative for AI lung scan analysis in fight against COVID-19 goes European
Icovid is being rolled out across Europe and is on the OECD shortlist for AI initiatives against current and future pandemics The Belgian initiative icovid, which supports radiologists in the assessm
Icovid is being rolled out across Europe and is on the OECD shortlist for AI initiatives against current and future pandemics The Belgian initiative icovid, which supports radiologists in the assessm
Half a million for cardiovascular anomalies research
The first Generet Award, which was launched this year, has gone to Professor Miikka Vikkula (de Duve Institute - UCLouvain) for his research seeking a genetic explanation for vascular anomalies.
The first Generet Award, which was launched this year, has gone to Professor Miikka Vikkula (de Duve Institute - UCLouvain) for his research seeking a genetic explanation for vascular anomalies.
Life Sciences - Sep 18
Human tissue waste a possible solution for cruelty-free research into male infertility
Human tissue waste a possible solution for cruelty-free research into male infertility
Research management - Aug 15
Ghent University remains first Belgian university in Academic Ranking of World Universities (Shanghai Ranking)
Ghent University remains first Belgian university in Academic Ranking of World Universities (Shanghai Ranking)
